Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
Open Access
- 1 January 2012
- journal article
- Published by Korean Society of Interventional Neuroradiology in Neurointervention
- Vol. 7 (1), 23-26
- https://doi.org/10.5469/neuroint.2012.7.1.23
Abstract
VerifyNow antiplatelet assays were performed before and after stenting for various cerebral artery stenoses to determine the effect of the procedure itself to the function of dual antiplatelets given. A total of 30 consecutive patients underwent cerebral arterial stenting procedure were enrolled. The antiplatelet pretreatment regimen was aspirin (100 mg daily) and clopidogrel (300 mg of loading dose followed by 75mg daily). VerifyNow antiplatelet assay performed before and right after stenting. The two test results were compared in terms of aspirin-reaction unit (ARU), P2Y12 reaction units (PRU), baseline (BASE), and percentage inhibition. We evaluated occurrence of any intra-procedural in-stent thrombosis or immediate thromboembolic complication, and ischemic events in 1-month follow-up. The median Pre-ARU was 418 (range, 350-586). For clopidogrel the medians of the pre-BASE, PRU, and percent inhibition were 338 (279-454), 256 (56-325), and 27% (0-57%). The medians of the post-ARU, BASE, PRU, and percent inhibition after stenting were 469 (range, 389-573), 378 (288-453), 274 (81-370), and 26% (0-79%). There was a significant increase of ARU (p=0.045), BASE (p=0.026), and PRU (p=0.018) before and after stenting. One immediate thromboembolic event was observed in poor-response group after stenting. There was no in-stent thrombosis and ischemic event in 1-month follow-up. We observed a significant increase of platelet reactivity to dual antiplatelet therapy right after stenting procedure for various cerebral arterial stenoses.Keywords
Funding Information
- Korea Health 21 Research and Development Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (A102065)
This publication has 17 references indexed in Scilit:
- Preinterventional Clopidogrel Response Variability for Coil Embolization of Intracranial Aneurysms: Clinical ImplicationsAmerican Journal of Neuroradiology, 2010
- Dual Antiplatelet Therapy Monitoring for Neurointerventional Procedures Using a Point-of-Care Platelet Function Test: A Single-Center ExperienceAmerican Journal of Neuroradiology, 2008
- The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administrationThrombosis and Haemostasis, 2008
- Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) studyThrombosis Research, 2007
- Aspirin and Clopidogrel Resistance: Consideration and ManagementJournal of Interventional Cardiology, 2006
- Neuroform In-Stent Stenosis: Incidence, Natural History and Treatment StrategiesNeurosurgery, 2006
- Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrelMethods and Findings in Experimental and Clinical Pharmacology, 2006
- Outcome of Endovascular Treatment in Symptomatic Intracranial Vascular StenosisKorean Journal of Radiology, 2005
- Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA)Stroke, 2004
- Clopidogrel for Coronary StentingCirculation, 2003